دورية أكاديمية

Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study

التفاصيل البيبلوغرافية
العنوان: Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study
المؤلفون: Vlachopoulos, C., Massia, D., Kochiadakis, G., Kolovou, G., Patsilinakos, S., Bridges, I., Sibartie, M., Dhalwani, N.N., Liberopoulos, E., Ray, K.K.
المساهمون: Amgen
المصدر: Hellenic Journal of Cardiology ; volume 74, page 74-76 ; ISSN 1109-9666
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Cardiology and Cardiovascular Medicine
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.hjc.2023.09.003
الإتاحة: https://doi.org/10.1016/j.hjc.2023.09.003Test
https://api.elsevier.com/content/article/PII:S1109966623001537?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1109966623001537?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.63E13799
قاعدة البيانات: BASE